5IV4 | Crystal structure of the human soluble cyclase in complex with the allosteric inhibitor LRE1 | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Kleinboelting, S., Steegborn, C. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.79 | ||||||||||||
ligand | ACT, CL, CME, DMS, EDO, GOL, LRI, PEG | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Discovery of LRE1 as a specific and allosteric inhibitor of soluble adenylyl cyclase., Ramos-Espiritu L, Kleinboelting S, Navarrete FA, Alvau A, Visconti PE, Valsecchi F, Starkov A, Manfredi G, Buck H, Adura C, Zippin JH, van den Heuvel J, Glickman JF, Steegborn C, Levin LR, Buck J, Nat Chem Biol. 2016 Aug 22. doi: 10.1038/nchembio.2151. PMID:27547922 |
Data retrieval |
View 5IV4 in 3D |
Visual 3D analysis of 5IV4 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5IV4 |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |